Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features.

By D. Dohan, J. Choukroun, A. Diss, Steve L Dohan, A. Dohan, J. Mouhyi, B. Gogly. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2006

1,216 citations recorded by the source corpus.

Subfields: Hematology, Pharmacy, Urology

View Paper: https://www.semanticscholar.org/paper/8bd5fe33309fc46619d4d40a6087d4ce4772e563

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

1. P. Doglioli
2. D. M. Dohan Ehrenfest
3. G. Sammartino
4. G. M. de Peppo

In Urology

1. P. Doglioli
2. D. M. Dohan Ehrenfest
3. G. Sammartino
4. G. M. de Peppo

Citations in the corpus

• Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies (2009, methodology): “Previous studies suspected this phenomenon with indirect proofs (Dohan et al. 2006a,b): after quantification of many different residual cytokines (growth factors and interleukins) within the supernatant and the clot exudate soon after PRF preparation, the cytokine amounts were found very low in…”